|
EXOSC10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.697800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.182770E-04 |
| Normal-vs-Stage2 |
1.943780E-01 |
| Normal-vs-Stage3 |
7.065000E-01 |
| Normal-vs-Stage4 |
3.134000E-01 |
| Stage1-vs-Stage2 |
2.314600E-01 |
| Stage1-vs-Stage3 |
1.259850E-03 |
| Stage1-vs-Stage4 |
2.792400E-02 |
| Stage2-vs-Stage3 |
2.962200E-01 |
| Stage2-vs-Stage4 |
5.962600E-01 |
| Stage3-vs-Stage4 |
5.418600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.071610E-02 |
| Normal-vs-AfricanAmerican |
1.350830E-01 |
| Normal-vs-Asian |
5.966500E-04 |
| Caucasian-vs-AfricanAmerican |
9.035000E-01 |
| Caucasian-vs-Asian |
4.988000E-02 |
| AfricanAmerican-vs-Asian |
1.093960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.294200E-02 |
| Normal-vs-Female |
1.141230E-03 |
| Male-vs-Female |
1.390560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.408800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.036100E-04 |
| Normal-vs-Age(61-80Yrs) |
5.026300E-02 |
| Normal-vs-Age(81-100Yrs) |
7.019400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.125200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.396200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.854600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.703700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.550400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.716210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.98639999898975E-08 |
| Normal-vs-Grade 2 |
3.75269999997041E-06 |
| Normal-vs-Grade 3 |
4.641200E-01 |
| Normal-vs-Grade 4 |
7.634800E-01 |
| Grade 1-vs-Grade 2 |
1.111840E-02 |
| Grade 1-vs-Grade 3 |
3.96560000004431E-06 |
| Grade 1-vs-Grade 4 |
1.55089999998026E-06 |
| Grade 2-vs-Grade 3 |
1.57732999999105E-05 |
| Grade 2-vs-Grade 4 |
8.22100000000825E-05 |
| Grade 3-vs-Grade 4 |
3.445200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.44849999994534E-07 |
| Normal-vs-ccB subtype |
9.018800E-01 |
| ccA subtype-vs-ccB subtype |
1.48219999607235E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.023500E-02 |
| Normal-vs-N1 |
8.581200E-01 |
| N0-vs-N1 |
4.669800E-01 |
|
|
